Skip to main content
. 2019 Jan 31;55(2):33. doi: 10.3390/medicina55020033

Table 2.

Patients’ age and colistin use in patients with different renal functional state.

Normal Renal Function ARC Renal Impairment CRRT Statistical Significance *
Median age (Q1; Q3), years 66 (59; 76) 49 (40; 61) 65 (56; 80) 60.5 (49; 71) 0.0005
Median duration of colistin therapy (Q1; Q3), days 9 (7;17) 16 (7; 27) 10 (4; 15) 11.5 (7; 24) 0.3440
Median cumulative colistin dose (Q1; Q3), MU 78 (45; 135) 107.5 (60; 171) 72 (30; 186) 70.3 (52; 141) 0.7140

* Kruskal-Wallis test.